Results 161 to 170 of about 1,622,974 (278)

Recent Development of Endo‐hepatology

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Endo‐hepatology is a rapidly evolving field encompassing endoscopic diagnosis and treatment of hepatobiliary diseases, primarily using endoscopic ultrasound (EUS). Since its conceptualization in 2012, the field has expanded dramatically alongside advances in interventional EUS. A landmark 2024 review broadened the concept to include endoscopic
Akira Yamamiya, Atsushi Irisawa, Yasunori Inaba, Rafael Romero‐Castro   +3 more
wiley   +1 more source

Diagnostic Performance of Magnetic Resonance Elastography Versus Vibration‐Controlled Transient Elastography for Liver Fibrosis Staging in Steatotic Liver Disease

NMR in Biomedicine, Volume 39, Issue 12, December 2026.
In 91 patients, vibration‐controlled transient elastography, two‐dimensional acoustic magnetic resonance elastography, and two‐ and three‐dimensional gravitational magnetic resonance elastography were compared for liver fibrosis assessment, with 35 biopsy‐confirmed cases.
Leon David Gruenewald, Christian Booz, Jennifer Gotta, Philipp Reschke, Tommaso D'Angelo, Nicole Suarez Ziegengeist, Katerina Torgashov, Laura Hempfling, Scherwin Mahmoudi, Lisa Reisbeck, Renate Maria Hammerstingl, Stefan Zeuzem, Esra Görgülü, Anita Pathil‐Warth, Melis Onay, Eva Herrmann, Iulia Dahmer, Raja Idris, Maria Johanna Gobertina Tetuanui Vehreschild, Katharina Schregel, Christof Matthias Sommer, Sandra Ciesek, Katrin Eichler, Thomas Joseph Vogl, Ralph Sinkus, Sebastian Haberkorn, Vitali Koch   +26 more
wiley   +1 more source

Evaluation of Diagnostic Accuracy of Combined Ultrasound Elastography and Magnetic Resonance Imaging in Breast Cancer. [PDF]

Breast Cancer (Dove Med Press)
Zhang P, Gu Y.
europepmc   +1 more source

Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates

Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 10931-10949, December 2026.
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou, Christoforos K. Travlos, Lucas Lage Marinho, Thomas A. Mavrakanas, João Pedro Ferreira, Abhinav Sharma   +5 more
wiley   +1 more source

Assessment of Medial Gastrocnemius Thickness and Stiffness in Children with Obesity Using Shear Wave Elastography. [PDF]

Children (Basel)
Dağ N, Dündar İ, Güngör Ş, Tasolar S, Er Ulubaba H, Akyol R, Güngör ED.   +6 more
europepmc   +1 more source

Non‐Invasive Fibrosis Testing in Adults With Obesity and MASLD: A Systematic Review and Meta‐Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11578-11590, December 2026.
ABSTRACT Aims Adults with obesity are at increased risk of metabolic dysfunction‐associated steatotic liver disease (MASLD)‐related fibrosis, but the diagnostic performance of non‐invasive tests (NITs) in this population remains uncertain. This meta‐analysis evaluated NITs for detecting significant (≥F2) and advanced (≥F3) fibrosis in adults with ...
Patricia M. Ortega, Lucas Sabatella, Pinelopi Manousou, Adriana Arregui, Ahmed R. Ahmed, Chioma Izzi‐Engbeaya   +5 more
wiley   +1 more source

Effect of Hashimoto's thyroiditis background on the diagnostic performance of deep fusion ultrasound elastography for benign and malignant thyroid nodules. [PDF]

Am J Transl Res
Yang Z, Zhou X, Peng S, Fu Z, Deng X, Shen L.   +5 more
europepmc   +1 more source

Machine learning models of noninvasive tests to predict metabolic dysfunction-associated steatohepatitis and fibrosis stage. [PDF]

Hepatol Commun
Loomba R, Taub R, Labriola D, Priel J, Padmanabhan K, Kim WR.   +5 more
europepmc   +1 more source

Anti‐Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The REACH‐B Study

Journal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
ABSTRACT Treatment indication for chronic hepatitis B (CHB) varies across clinical guidelines. This study evaluated treatment eligibility and uptake in a large Australian cohort of people with CHB. The REACH‐B study recruited people with CHB managed through a national network of healthcare services.
Behzad Hajarizadeh, Renjy Nelson, Jacob George, Josh Hanson, Jane Davies, Marianne Martinello, Tracey Brown, Ian Wong, Tasnim Hasan, Lester Mascarenhas, James O'Beirne, Amanda Wade, Marilou Capati, Georgina Trotter, Sarah Thomas, Lloyd Nash, Benjamin Cowie, Nicole Allard, Thomas Tu, Lien Tran, Stephanie Howard, Robert Monaghan, Jessica Carter, Elise Tu, Amanda Erratt, Joanne Carson, Gregory J. Dore, Gail V. Matthews, on behalf of the REACH‐B Study Group   +28 more
wiley   +1 more source

Correlation and discriminatory performance of non-invasive serum fibrosis indices according to liver disease etiology using two-dimensional shear wave elastography as reference. [PDF]

Clinics (Sao Paulo)
Galaviz-Valdez ME, Torres-González L, Izaguirre-García JR, Muñoz-Espinosa LE, Moreno-Peña DP, Rodríguez-Rodríguez DR, Cura-Esquivel IA, Cordero-Pérez P.   +7 more
europepmc   +1 more source